All are on the rise in the United States and, with the increasing prevalence of obesity and diabetes, have been described as an epidemic. Did you know that in 2013 the leading cause of death was cardiovascular disease? This affects us all. People either have heart disease, will get heart disease, or know someone who has heart disease. The demand is high for a greater understanding of how cardiovascular disease develops and for new and better treatments. This is the mission of the Vascular Biology Center. We have brought together an internationally recognized team of experts determined to make breakthroughs in the prevention and treatment of cardiovascular disease. Our field is developing rapidly, our science is critical, not only for the health of our country, but the rest of the world.
It’s the proportionately of a newborn — a measure that includes both birthweight and length — that may best tell doctors whether a child is born with an increased risk for heart problems later in life, investigators report.
A synthetic peptide disrupts the destructive inflammation that occurs in nephritis, enabling the kidneys to better recover and maintain function.
After competing against a nationwide pool of doctoral students, three students in the Vascular Biology Center were awarded 2019 AHA Predoctoral Fellowship Grants.
Dr. Brian K. Stansfield, who is a 2004 MCG graduate, will lead the group through 2020 and will organize its annual meeting in New Orleans next year.
